Article Details
Retrieved on: 2024-01-31 21:52:41
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Pfizer's revenue decline due in part to reduced sales of its COVID vaccine, developed with BioNTech, and Paxlovid (Nirmatrelvir/ritonavir), despite U.S. R&D efforts.
Article found on: www.thetimes.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here